|
Volumn 18, Issue 7, 2003, Pages 653-655
|
Pharmacological treatment of frontotemporal dementia: Treatment response to the MAO-A inhibitor moclobemide
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALBUMIN;
MOCLOBEMIDE;
MONOAMINE OXIDASE A INHIBITOR;
ADULT;
AFFECTIVE NEUROSIS;
AGED;
AGGRESSIVENESS;
ARTICLE;
BEHAVIOR DISORDER;
BRAIN ATROPHY;
BRAIN BIOPSY;
CEREBROSPINAL FLUID ANALYSIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COGNITIVE DEFECT;
DEPRESSION;
DISEASE SEVERITY;
DISTRACTIBILITY;
DRUG DOSE REGIMEN;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG TOLERABILITY;
ELECTROENCEPHALOGRAPHY;
FAMILY HISTORY;
FEMALE;
FRONTOTEMPORAL DEMENTIA;
HOSPITAL ADMISSION;
HUMAN;
IRRITABILITY;
MALE;
MENTAL HOSPITAL;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OPEN STUDY;
PSYCHOMOTOR DISORDER;
PSYCHOPATHY;
SLOW BRAIN WAVE;
SPEECH DISORDER;
STEREOTYPY;
SYMPTOMATOLOGY;
AGED;
ANTIDEPRESSIVE AGENTS;
FEMALE;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
MOCLOBEMIDE;
MONOAMINE OXIDASE INHIBITORS;
PICK DISEASE OF THE BRAIN;
TREATMENT OUTCOME;
|
EID: 0042370329
PISSN: 08856230
EISSN: None
Source Type: Journal
DOI: 10.1002/gps.894 Document Type: Article |
Times cited : (28)
|
References (5)
|